121 Nº
Idade
Diag.
(meses) Clínico
Diag.
Revisão
Trat. Sist.
GLUT1
Ki-67
VEGF
NOS3
p53
Bcl-2
Bcl-X
Bax
Bak
FAS
FAS-L Casp.3 TUNEL
Biol.
Morfol.
91
50
HT
HP
FIBROG
N
70,37
N
N
P
N
PF
PF
P
P
P
N
.
92
61
HT
HP
PROL
N
41,43
N
PF
N
N
NA
NA
NA
P
P
N
.
93
57
HF
HP
FIBROG
N
10,18
N
N
N
N
PF
PF
P
P
P
N
.
94
50
HT
HP
PROL
P
3,71
P
PF
N
N
P
P
P
P
P
P
.
95
68
HT
HP
FIBROG
N
4,02
N
PF
N
N
P
P
P
P
P
N
.
96
60
HF
HP
FIBROG
N
0,74
N
N
N
N
P
P
P
P
P
N
.
97
87
HT
HP
FIBROG
P
0
P
PF
N
N
P
P
P
P
P
N
.
98
78
L
MF
MF
N
4,73
.
.
.
.
.
.
.
.
.
.
.
99
19
L
MF
MF
N
1,86
.
.
.
.
.
.
.
.
.
.
.
100
52
HT
HP
FIBROG
P
12,96
N
P
P
N
P
P
N
P
P
N
.
101
29
HT
HP
PROL
P
8,09
P
P
P
N
P
P
P
P
P
N
22,20
102
79
L
MF
MF
N
0,83
.
.
.
.
.
.
.
.
.
.
.
103
37
HF
HP
PROL
P
2,92
P
P
P
N
PF
P
P
P
P
N
.
104
70
HP
MF
PROL
N
8,63
.
.
.
.
.
.
.
.
.
.
.
105
60
HF
HP
MF
N
0
N
PF
NA
N
PF
P
P
P
P
N
.
106
141
HF
HP
MF
N
0
N
P
N
N
P
P
P
P
P
N
.
107
86
HT
HP
MF
56
N
0
N
P
N
N
N
P
N
P
P
N
.
108
42
HT
HP
PROL
42
P
1,43
P
P
P
N
P
P
P
P
P
N
.
109
58
HT
HP
FIBROG
N
0
N
PF
N
N
PF
PF
N
P
P
N
.
110
136
HP
MF
PROL
N
4,12
.
.
.
.
.
.
.
.
.
.
.
111
56
HT
HP
MF
N
1,08
P
P
N
N
NA
PF
P
P
P
N
.
112
26
L
MF
MF
N
0,87
.
.
.
.
.
.
.
.
.
.
.
113
37
L
MF
MF
N
0,88
.
.
.
.
.
.
.
.
.
.
.
114
47
L
MF
MF
N
0,84
.
.
.
.
.
.
.
.
.
.
.
115
24
HT
HP
PROL
P
4,72
P
PF
N
N
P
P
P
P
P
PFc
3,40
116
48
L
MF
MF
N
0
.
.
.
.
.
.
.
.
.
.
.
117
23
HT
HP
PROL
P
0,89
P
PF
P
N
P
P
P
P
P
PFc
64,00
118
73
HC
MF
MF
N
0
.
.
.
.
.
.
.
.
.
.
.
119
36
HT
HP
PROL
P
0
.
.
.
.
.
.
.
.
.
.
.
120
47
HT
HP
PROL
P
0,17
N
PF
P
N
P
P
P
P
P
N
.
120
70 193
412
31
(%)
PDF created with pdfFactory trial version www.pdffactory.com
(%)